A total of 80 children with CAP admitted to Duchang County Maternal and Child Health Hospital from January 2021 to September 2024 were selected as the research objects and randomly divided into two groups. The control group (40 cases) was given conventional anti-infection treatment, and the observation group (40 cases) was given methylprednisolone on the basis of the control group. The clinical efficacy, symptom improvement time, inflammatory factor level, quality of life and adverse reactions were compared between the two groups.
Results The total effective rate of the observation group was higher than that of the control group, with statistical difference (
P<0.05); The improvement time of each symptom in the observation group was shorter than that in the control group, with statistical difference (
P<0.05); After treatment, the levels of high-sensitivity C-reactive protein (hs-CRP), interleukin (IL)-8, procalcitonin (PCT), tumor necrosis factor-α (TNF-α), IL-6 in the observation group were lower than those in the control group, and the scores of children's quality of life universal core scale (PedsQLTM 4.0) were higher than those in the control group, with statistical differences (
P<0.05); The incidence of adverse reactions in the observation group was similar to that in the control group, with no statistical difference (
P>0.05).
Conclusion Methylprednisolone adjuvant treatment of CAP can improve the curative effect, accelerate the improvement of symptoms, reduce the level of body inflammation, help to improve the quality of life of children, and is safe and reliable.